Literature DB >> 7823023

Porters and neurotransmitter transporters.

N Nelson1, H Lill.   

Abstract

Uptake of neurotransmitters involves multiple transporters acting in different brain locations under different physiological conditions. The vesicular transporters are driven by a proton-motive force generated by a V-ATPase and their substrates are taken up via proton/substrate exchange. The plasma membrane transporters are driven by an electrochemical gradient of sodium generated by a Na+/K(+)-ATPase. Two distinct families of transporters were identified in this group. One cotransports sodium with glutamate and other amino acids and requires additionally an outwardly directed potassium gradient. The second cotransports sodium, chloride and a variety of neurotransmitters, including gamma-aminobutyric acid (GABA), glycine and monoamines. Genes and cDNA encoding several members of the latter family have been cloned and studied in detail. The structure and function as well as the evolutionary relationships among these neurotransmitter transporters are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7823023     DOI: 10.1242/jeb.196.1.213

Source DB:  PubMed          Journal:  J Exp Biol        ISSN: 0022-0949            Impact factor:   3.312


  9 in total

Review 1.  Bioenergetics of neurotransmitter transport.

Authors:  G Rudnick
Journal:  J Bioenerg Biomembr       Date:  1998-04       Impact factor: 2.945

2.  A variant of the bovine noradrenaline transporter reveals the importance of the C-terminal region for correct targeting to the membrane and functional expression.

Authors:  L D Burton; A G Kippenberger; B Lingen; M Brüss; H Bönisch; D L Christie
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

3.  Functional sensitivity of polar surfaces on transmembrane helix 8 and cytoplasmic loop 8-9 of the Escherichia coli GABA (4-aminobutyrate) transporter encoded by gabP: mutagenic analysis of a consensus amphipathic region found in transporters from bacteria to mammals.

Authors:  L A Hu; S C King
Journal:  Biochem J       Date:  1998-03-01       Impact factor: 3.857

4.  The NH(2)-terminus of norepinephrine transporter contains a basolateral localization signal for epithelial cells.

Authors:  H H Gu; X Wu; B Giros; M G Caron; M J Caplan; G Rudnick
Journal:  Mol Biol Cell       Date:  2001-12       Impact factor: 4.138

5.  Human, rat and chicken small intestinal Na+ - Cl- -creatine transporter: functional, molecular characterization and localization.

Authors:  M J Peral; M García-Delgado; M L Calonge; J M Durán; M C De La Horra; T Wallimann; O Speer; A Ilundáin
Journal:  J Physiol       Date:  2002-11-15       Impact factor: 5.182

6.  Differential effects of K(ATP) channel blockers on [(3)H]-noradrenaline overflow after short- and long-term exposure to (+)-oxaprotiline or desipramine.

Authors:  Klaus Eckhardt; Patrick Roth; Thomas Günter; Sascha Schmidt; Thomas J Feuerstein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-01-18       Impact factor: 3.000

7.  Plasma membrane transporters of serotonin, dopamine, and norepinephrine mediate serotonin accumulation in atypical locations in the developing brain of monoamine oxidase A knock-outs.

Authors:  O Cases; C Lebrand; B Giros; T Vitalis; E De Maeyer; M G Caron; D J Price; P Gaspar; I Seif
Journal:  J Neurosci       Date:  1998-09-01       Impact factor: 6.167

8.  ICA 512, an autoantigen of type I diabetes, is an intrinsic membrane protein of neurosecretory granules.

Authors:  M Solimena; R Dirkx; J M Hermel; S Pleasic-Williams; J A Shapiro; L Caron; D U Rabin
Journal:  EMBO J       Date:  1996-05-01       Impact factor: 11.598

9.  Kinetics of creatine ingested as a food ingredient.

Authors:  Louise Deldicque; Jacques Décombaz; Hermann Zbinden Foncea; Jacques Vuichoud; Jacques R Poortmans; Marc Francaux
Journal:  Eur J Appl Physiol       Date:  2007-09-13       Impact factor: 3.078

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.